Terms: = Brain cancer AND WIF1, WIF-1, 11197, ENSG00000156076
22 results:
1. Gene Expression Patterns Associated with Survival in Glioblastoma.
Morrison C; Weterings E; Gravbrot N; Hammer M; Weinand M; Sanan A; Pandey R; Mahadevan D; Stea B
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612480
[TBL] [Abstract] [Full Text] [Related]
2. Dysregulated miR-137 and its target EGFR contribute to the progression of pituitary adenomas.
Wei D; Yu Z; Cheng Y; Jiawei H; Jian G; Hua G; Guilan D
Mol Cell Endocrinol; 2021 Jan; 520():111083. PubMed ID: 33246030
[TBL] [Abstract] [Full Text] [Related]
3. Predicting the regrowth of clinically non-functioning pituitary adenoma with a statistical model.
Cheng S; Wu J; Li C; Li Y; Liu C; Li G; Li W; Hu S; Ying X; Zhang Y
J Transl Med; 2019 May; 17(1):164. PubMed ID: 31109334
[TBL] [Abstract] [Full Text] [Related]
4. Identification of Important Invasion-Related Genes in Non-functional Pituitary Adenomas.
Joshi H; Vastrad B; Vastrad C
J Mol Neurosci; 2019 Aug; 68(4):565-589. PubMed ID: 30982163
[TBL] [Abstract] [Full Text] [Related]
5. Knockdown of HOXC6 inhibits glioma cell proliferation and induces cell cycle arrest by targeting wif-1 in vitro and vivo.
Yan TF; Wu MJ; Xiao B; Hu Q; Fan YH; Zhu XG
Pathol Res Pract; 2018 Nov; 214(11):1818-1824. PubMed ID: 30228024
[TBL] [Abstract] [Full Text] [Related]
6. Association of TGF-β1 and wif1 Expression with 36 Paired Primary/Recurrent Nonfunctioning Pituitary Adenomas: A High-Throughput Tissue Microarrays Immunohistochemical Study.
Zhu H; Yao X; Wu L; Li C; Bai J; Gao H; Ji H; Zhang Y
World Neurosurg; 2018 Nov; 119():e23-e31. PubMed ID: 29966778
[TBL] [Abstract] [Full Text] [Related]
7. Aberrant expression of the sFRP and wif1 genes in invasive non-functioning pituitary adenomas.
Song W; Qian L; Jing G; Jie F; Xiaosong S; Chunhui L; Yangfang L; Guilin L; Gao H; Yazhuo Z
Mol Cell Endocrinol; 2018 Oct; 474():168-175. PubMed ID: 29555596
[TBL] [Abstract] [Full Text] [Related]
8. In vivo characterization of brain metabolism by
Lai M; Vassallo I; Lanz B; Poitry-Yamate C; Hamou MF; Cudalbu C; Gruetter R; Hegi ME
Int J Cancer; 2018 Jul; 143(1):127-138. PubMed ID: 29417580
[TBL] [Abstract] [Full Text] [Related]
9. Native Oligodendrocytes in Astrocytomas Might Inhibit Tumor Proliferation by wif1 Expression.
Asslaber M; Schauer S; Gogg-Kamerer M; Bernhart E; Quehenberger F; Haybaeck J
J Neuropathol Exp Neurol; 2017 Jan; 76(1):16-26. PubMed ID: 28040794
[TBL] [Abstract] [Full Text] [Related]
10. Blood-brain Barrier Breakdown Determines Differential Therapeutic Outcome in Genetically Diverse Forms of Medulloblastoma.
Guerit S; Liebner S
Cancer Cell; 2016 Apr; 29(4):427-429. PubMed ID: 27070693
[TBL] [Abstract] [Full Text] [Related]
11. Norcantharidin blocks Wnt/β-catenin signaling via promoter demethylation of wif-1 in glioma.
Xie D; Xie J; Wan Y; Ma L; Qi X; Wang K; Yang S
Oncol Rep; 2016 Apr; 35(4):2191-7. PubMed ID: 26781164
[TBL] [Abstract] [Full Text] [Related]
12. wif1 re-expression in glioblastoma inhibits migration through attenuation of non-canonical WNT signaling by downregulating the lncRNA MALAT1.
Vassallo I; Zinn P; Lai M; Rajakannu P; Hamou MF; Hegi ME
Oncogene; 2016 Jan; 35(1):12-21. PubMed ID: 25772239
[TBL] [Abstract] [Full Text] [Related]
13. miR-603 promotes glioma cell growth via Wnt/β-catenin pathway by inhibiting wif1 and CTNNBIP1.
Guo M; Zhang X; Wang G; Sun J; Jiang Z; Khadarian K; Yu S; Zhao Y; Xie C; Zhang K; Zhu M; Shen H; Lin Z; Jiang C; Shen J; Zheng Y
Cancer Lett; 2015 Apr; 360(1):76-86. PubMed ID: 25681036
[TBL] [Abstract] [Full Text] [Related]
14. SHH, WNT, and NOTCH pathways in medulloblastoma: when cancer stem cells maintain self-renewal and differentiation properties.
Cordeiro BM; Oliveira ID; Alves MT; Saba-Silva N; Capellano AM; Cavalheiro S; Dastoli P; Toledo SR
Childs Nerv Syst; 2014 Jul; 30(7):1165-72. PubMed ID: 24695855
[TBL] [Abstract] [Full Text] [Related]
15. Suppression of MMQ cells by fulvestrant: possible mechanism of action and potential application for bromocriptine-resistant prolactinomas.
Bai J; Gui S; Zhang Y
J Clin Neurosci; 2013 May; 20(5):721-5. PubMed ID: 23523357
[TBL] [Abstract] [Full Text] [Related]
16. Promoter methylation of WNT inhibitory factor-1 and expression pattern of WNT/β-catenin pathway in human astrocytoma: pathologic and prognostic correlations.
Kim SA; Kwak J; Nam HY; Chun SM; Lee BW; Lee HJ; Khang SK; Kim SW
Mod Pathol; 2013 May; 26(5):626-39. PubMed ID: 23328978
[TBL] [Abstract] [Full Text] [Related]
17. Wnt inhibitory factor-1 regulates glioblastoma cell cycle and proliferation.
Wu J; Fang J; Yang Z; Chen F; Liu J; Wang Y
J Clin Neurosci; 2012 Oct; 19(10):1428-32. PubMed ID: 22901505
[TBL] [Abstract] [Full Text] [Related]
18. The Wnt inhibitory factor 1 (wif1) is targeted in glioblastoma and has a tumor suppressing function potentially by induction of senescence.
Lambiv WL; Vassallo I; Delorenzi M; Shay T; Diserens AC; Misra A; Feuerstein B; Murat A; Migliavacca E; Hamou MF; Sciuscio D; Burger R; Domany E; Stupp R; Hegi ME
Neuro Oncol; 2011 Jul; 13(7):736-47. PubMed ID: 21642372
[TBL] [Abstract] [Full Text] [Related]
19. Expression and aberrant promoter methylation of Wnt inhibitory factor-1 in human astrocytomas.
Yang Z; Wang Y; Fang J; Chen F; Liu J; Wu J; Wang Y
J Exp Clin Cancer Res; 2010 Mar; 29(1):26. PubMed ID: 20334650
[TBL] [Abstract] [Full Text] [Related]
20. TWIST-1 is overexpressed in neoplastic choroid plexus epithelial cells and promotes proliferation and invasion.
Hasselblatt M; Mertsch S; Koos B; Riesmeier B; Stegemann H; Jeibmann A; Tomm M; Schmitz N; Wrede B; Wolff JE; Zheng W; Paulus W
Cancer Res; 2009 Mar; 69(6):2219-23. PubMed ID: 19276370
[TBL] [Abstract] [Full Text] [Related]
[Next]
